Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Children with better, longer sleep more likely to have better weight

09 Nov 2019
The growing obsession with the internet is one of the reasons leading to sleep deprivation.

Longer sleep in children is tied to reduced body mass index (BMI) and lower risks of becoming overweight or obese, regardless of socioeconomic status, a recent study has found.

Researchers performed a cross-sectional analysis on 382 children (mean age, 8.47±0.45 years; 49.5 percent female), a quarter of whom were living at or below the poverty line. Participants were assessed at 12 months of age for their socioeconomic status, while sleep and weight indicators were evaluated at 8 years of age.

Longer sleep duration at 8 years correlated with significantly lower BMI (estimate, –0.50±0.23; p≤0.05) and the risk of becoming overweight or obese (odds ratio, 0.52, 95 percent confidence intervals [CI], 0.34–0.78; p≤0.01). No such effect was reported for percent body fat and waist circumference.

Moreover, socioeconomic status both at 12 months and at 8 years of life was not associated with any of the weight indicators.

Notably, despite having no main relationship with BMI, the effect of sleep efficiency appeared to be modified by early life socioeconomic status. In particular, greater sleep efficiency was significantly predictive of lower BMI only in children belonging to families of low socioeconomic status (p<0.001). In absolute terms, each 5-percent increase in sleep efficiency led to a 0.5-point decrease in BMI.

“Findings identify early socioeconomic status as a potent moderator of associations between sleep and weight indicators in middle childhood and inform clinicians that maximizing and improving child sleep quantity and quality may be candidate targets for interventions looking to reduce BMI and obesity, particularly for children who experience fewer resources early in life,” said researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.